Metabolic reprogramming in esophageal squamous cell carcinoma

Esophageal squamous cell carcinoma (ESCC) is a malignancy with high incidence in China. Due to the lack of effective molecular targets, the prognosis of ESCC patients is poor. It is urgent to explore the pathogenesis of ESCC to identify promising therapeutic targets. Metabolic reprogramming is an em...

Full description

Bibliographic Details
Published in:Frontiers in Pharmacology
Main Authors: Ziyi Wang, Xiangyu Sun, Zehui Li, Huidong Yu, Wenya Li, Yan Xu
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-06-01
Subjects:
metabolic reprogramming
glucose
fatty acid
amino acid
esophageal cancer
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2024.1423629/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2024.1423629/full

Similar Items